Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-07-31

Clinical Trial Update: Letermovir in ART-treated HIV-infected Persons [NA]

View source ↗

Summary

Clinical trial NCT05362916 evaluating letermovir in ART-treated people living with HIV has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letermovir (letermovir)

Snippet

Sponsor: Jean-Pierre Routy | Conditions: People Living With HIV | NA | Status: COMPLETED